WO2025256615 - CRYSTAL FORM OF NEW GLUCOCORTICOID
National phase entry is expected:
Publication Number
WO/2025/256615
Publication Date
18.12.2025
International Application No.
PCT/CN2025/100819
International Filing Date
13.06.2025
Title **
[English]
CRYSTAL FORM OF NEW GLUCOCORTICOID
[French]
FORME CRISTALLINE D'UN NOUVEAU GLUCOCORTICOÏDE
[Chinese]
新型糖皮质激素的晶型
Applicants **
TIANJIN TIANYAO PHARMACEUTICALS CO., LTD.
Inventors
REN, Nan
HAN, Kunying
WANG, Ruina
SUN, Shuangyong
WANG, Yan
ZHANG, Jie
LIU, Dengke
Priority Data
202410770637.2
14.06.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1600 | |
| EPO | Filing, Examination, Granting | 11706 | |
| Japan | Filing, Examination, Granting | 1923 | |
| South Korea | Filing, Examination, Granting | 1586 | |
| USA | Filing, Examination, Granting | 5340 |
Total:
22,155
Contact Us
Abstract[English]
The present invention belongs to the field of medicine, specifically relates to a crystal form of a new glucocorticoid, and further relates to a pharmaceutical composition containing the crystal and the pharmaceutical use thereof.[French]
La présente invention relève du domaine de la médecine, concerne spécifiquement une forme cristalline d'un nouveau glucocorticoïde, et concerne en outre une composition pharmaceutique contenant le cristal et son utilisation pharmaceutique.[Chinese]
本发明属于医药领域，具体涉及新型糖皮质激素的晶型，还涉及包含晶型物的药物组合物及医药用途。